Salerno, Nadia
Ielapi, Jessica
Cersosimo, Angelica
Leo, Isabella
Di Costanzo, Assunta
Armentaro, Giuseppe
De Rosa, Salvatore
Sciacqua, Angela
Sorrentino, Sabato
Torella, Daniele
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (PNRR—National Center for Gene Therapy and Drugs based on RNA Technology No. CN00000041)
Ministero dell'Università e della Ricerca (PNRR—National Center for Gene Therapy and Drugs based on RNA Technology No. CN00000041)
Ministero dell'Università e della Ricerca (PNRR—National Center for Gene Therapy and Drugs based on RNA Technology No. CN00000041)
Ministero della Salute (POS4 “Cal-Hub-Ria” No. T4-AN-09; PNRRMAD-2022-12376814)
Article History
Received: 18 February 2025
Accepted: 20 March 2025
First Online: 26 March 2025
Declarations
:
: The study was approved by the Local Ethics Committee (Protocol Register No. 170, May 30, 2024). All patients provided written informed consent before participating in the study.
: All authors listed above approved the manuscript for publication.
: The authors declare no competing interests.